Watch for the annual meeting date and management's response (poison pill, settlement talks, or director withdrawals). The activist's track record (Cantaloupe sale at 89% return) and the company's cash-rich, no-debt balance sheet make this a credible campaign. Key catalysts: management's proxy statement, any director departures, and the final vote outcome.
Price Chart
Executive Summary
Doug Bergeron (DGB Investment, Inc.) filed additional definitive proxy soliciting materials on October 6, 2026, escalating his proxy fight to elect five director nominees at Ethan Allen's 2026 annual meeting. The filing includes an email blast to campaign subscribers and a LinkedIn post promoting a video series making the case for change. This follows Bergeron's initial 13D filing on August 5, 2026, where he disclosed a 5.0% stake and nominated six candidates, and an amended group agreement on August 27, 2026. The campaign targets Chairman/CEO Farooq Kathwari (38-year tenure) and a board Bergeron argues has failed to grow the business for two decades.
Key Financial Metrics
Key Facts
- Doug Bergeron (DGB Investment) owns 5.0% of Ethan Allen common stock.
- Bergeron nominated five director candidates: himself, Anna Brockway, Kristine Miller, Steve Oblak, and Stefanie Tsen Ward.
- The activist launched a website (EthanAllenGrowth.com), video series, and LinkedIn/X social channels.
- Bergeron previously led a successful proxy campaign at Cantaloupe (CTLP), which was sold for $848 million in 2026, generating an 89% total shareholder return.
- The filing references Ethan Allen's FY2026 Q4 results: meaningful annual sales decline, weaker written orders, compressed adjusted operating margins, and lower EPS.
- Ethan Allen has $187.5 million in total cash and investments and no debt.
- The activist argues the company has failed to grow revenue for two decades while competitors (RH, Williams-Sonoma, Arhaus) built multibillion-dollar platforms.
- The annual meeting date has not been disclosed in this filing.
Financial Impact
Activist campaign targeting board control at a company with $187.5M cash, no debt, and declining revenue. Bergeron claims the company can triple shareholder value over three years.
Risk Factors
- Management may adopt a poison pill or other defensive measures.
- The activist may fail to win board seats if retail shareholders side with management.
- Revenue decline and margin compression could worsen regardless of board change.
- The company's entrenched CEO (38 years) may resist change, prolonging the fight.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DFAN14A Filing (Primary) | 0000921895-26-002742 |
| Document: 0000921895-26-002742-index-headers.html | 0000921895-26-002742 |
| Document: 0000921895-26-002742-index.html | 0000921895-26-002742 |
| Document: 0000921895-26-002742.txt | 0000921895-26-002742 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DFAN14A | — | awaiting T+1 | — | — |
Oct 22, 2026 4d ago | DFAN14A | $20.45 $20.08 | ▼ −1.81% | ▼ −2.52% | $20.08 (−1.81%) |
Oct 19, 2026 7d ago | DEFA14A | $20.16 $19.78 | ▼ −1.88% | ▼ −2.41% | $20.08 (−0.40%) |
Oct 19, 2026 7d ago | Press Release | $19.77 $20.16 | ▲ +1.97% | ▲ +1.64% | $20.08 (+1.57%) |
Oct 19, 2026 7d ago | Press Release | $19.77 | awaiting T+1 | — | $20.08 (+1.57%) |
Oct 15, 2026 11d ago | DEFA14A | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.08 (+0.25%) |
Oct 15, 2026 11d ago | Press Release | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.08 (+0.25%) |
Oct 15, 2026 11d ago | DEFA14A | $20.03 $19.77 | ▼ −1.30% | ▼ −1.72% | $20.08 (+0.25%) |
Oct 13, 2026 13d ago | DEFA14A | $20.06 $20.36 | ▲ +1.50% | ▲ +1.21% | $20.08 (+0.10%) |
Oct 9, 2026 17d ago | DFAN14A | $20.32 $20.43 | ▲ +0.54% | ▲ +0.55% | $20.08 (−1.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers